Privacy Protection and the Disclosure of Health Information: Legal Issues for People Living with HIV/AIDS in Canada

This report focuses on three important areas of concern: the lack of adequate and effective protections in Canadian law for the right of people living with HIV/AIDS to keep their personal health information private; clauses in legislation that permit a person to disclose another person’s personal health information, including the health information of a person … Read more

Controlling Drug Costs for People Living with HIV/AIDS: Federal Regulation of Pharmaceutical Prices in Canada

The paper: highlights the significance of policy on pharmaceutical pricing, given increasing costs and spending on medicines as part of overall healthcare spending in Canada; identifies recent developments that are important because they inform current debates in Canada over regulating drug prices, or our policies in general relating to pharmaceuticals; outlines current federal law and … Read more

Network News 15 – May 2004

In this issue: Canada Proceeds with Bill C-9: Will Exports of Low-Cost Medicines to Developing Countries be the Result? An Interview with Richard Elliott “We are Having an Impact”: Interview with Ralf Jürgens Update: 60th Session of the UN Commission on Human Rights Progress on Joint Agenda for Microbicide, Treatment and Vaccines Advocates Cross-Canada Day … Read more

HIV/AIDS Policy and Law Review 9(1) April 2004

FEATURE HIV treatments, vaccines, and microbicides: toward coordinated advocacy CANADIAN NEWS Québec: An outbreak of HIV/AIDS-related stigma and discrimination Alberta: New bill will allow for mandatory HIV testing in emergency situations Media frenzy greets release of Newfoundland man from prison Health Canada makes marijuana available for medical use AIDS in the workplace: a program that’s … Read more

HIV treatments, vaccines, and microbicides: toward coordinated advocacy – HIV/AIDS Policy and Law Review 9(1), April 2004

In November 2003, the Legal Network convened a meeting in Montréal of global experts working in the fields of treatments, vaccines, and microbicides.The meeting was historic in that it was the first occasion on which advocates from the three fields had the opportunity to meet and exchange views on policy priorities. In this article, John … Read more